On June 27, the Centers for Medicare & Medicaid Services (CMS), Center for Medicaid and CHIP Services (CMCS) released guidance to states through State Release #185, titled State Medicaid Coverage of Drugs Approved by the FDA under Accelerated Approval Pathway. The release specifies that a drug approved by the Food and Drug Administration (FDA) under its “accelerated approval” pathway, must be covered by state Medicaid programs.
CMS Guidance on Medicaid Coverage of Drugs Approved by the FDA under Its “Accelerated Approval Pathway”
by familyvoices | Jul 3, 2018 | Family Voices, NCFPP, Washington Update